Primary Objective: \- To describe the clinical characteristics of participants with chronic rhinosinusitis with nasal polyps (CRSwNP) in terms of disease severity, Type 2 inflammation-related comorbidities (such as asthma and allergic rhinitis), other associated comorbidities, and treatments used in a real-world setting Secondary Objectives: * Describe the progression in treatment outcomes at different visits (baseline, 3 months, 6 months, and 12 months). * To assess the healthcare resource utilization of participants with CRSwNP in countries of the Gulf region (number of visits, emergency room (ER), surgery, etc).
Study Type
OBSERVATIONAL
Enrollment
148
Investigational Site Number: 01
Kuwait City, Kuwait
Percentage of participants with mild, moderate or severe disease (measured by visual analogue scale [VAS] score)
Time frame: Day 0 (baseline) to Month 12
The mean baseline Sinonasal Outcome Test (SNOT-22) scores
Time frame: Day 0
The mean baseline nasal polyps score (NPS)
Time frame: Day 0
Percentage of participants with Type 2 inflammation-related comorbidities including bronchial asthma, allergic rhinitis, atopic dermatitis, chronic spontaneous urticaria, eosinophilic esophagitis (EoE), and food allergy
Time frame: Day 0
Percentage of participants with other associated comorbidities including chronic obstructive pulmonary disease (COPD), ulcerative colitis, eosinophilic gastritis, or other comorbidities (if relevant)
Time frame: Day 0
Percentage of different medications used by participants with CRSwNP during the follow-up period as per decision of the treating physician
Time frame: Day 0 to Month 12
The mean change in the baseline Sinonasal Outcome Test (SNOT-22) scores
Time frame: Day 0 (baseline), Month 3, Month 6, and Month 12
The mean change in the baseline nasal polyps score (NPS)
Time frame: Day 0, Month 3, Month 6, and Month 12
Mean change in the baseline total symptoms score (TSS)
Time frame: Day 0, Month 6, and Month 12
The proportion of CRSwNP patients with hospitalization
Time frame: Day 0 to Month 12
The proportion of CRSwNP patients with emergency room (ER), office, or general practitioner visits
Time frame: Day 0 to Month 12
The mean number of days/visits to ER, office, or general practitioner
Time frame: Day 0 to Month 12
The mean number of days of sick leaves
Time frame: Day 0 to Month 12
The proportion of surgical procedures performed during the hospital visit including nasal polypectomy with additional sinus dissection, isolated nasal polypectomy, or functional endoscopic sinus surgery [FESS])
Time frame: Day 0 to Month 12
The mean number of participants with CRSwNP who need surgical treatment
Time frame: Day 0 to Month 12
Total number of surgeries
Time frame: Day 0 to Month 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.